Healthcare provider profile · identity verified

Amy W Doolan, D.O.

Family Practice · ROANOKE, VA · NPI 1265630248

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	396	131
Atorvastatin Calcium	Atorvastatin Calcium	366	141
Amlodipine Besylate	Amlodipine Besylate	325	118
Rosuvastatin Calcium	Rosuvastatin Calcium	256	82
Levothyroxine Sodium	Levothyroxine Sodium	238	74
Omeprazole	Omeprazole	225	84
Furosemide	Furosemide	184	69
Gabapentin	Gabapentin	178	58
Metformin Hcl	Metformin Hcl	170	63
Hydrochlorothiazide	Hydrochlorothiazide	155	57
Pantoprazole Sodium	Pantoprazole Sodium	150	62
Losartan Potassium	Losartan Potassium	143	52
Albuterol Sulfate Hfa	Albuterol Sulfate	142	52
Meloxicam	Meloxicam	135	53
Metoprolol Succinate	Metoprolol Succinate	124	46
Metoprolol Tartrate	Metoprolol Tartrate	123	44
Montelukast Sodium	Montelukast Sodium	116	44
Sertraline Hcl	Sertraline Hcl	114	41
Trazodone Hcl	Trazodone Hcl	108	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	101	27
Famotidine	Famotidine	96	37
Escitalopram Oxalate	Escitalopram Oxalate	94	27
Fluticasone Propionate	Fluticasone Propionate	94	40
Carvedilol	Carvedilol	91	35
Simvastatin	Simvastatin	85	31
Alprazolam	Alprazolam	81	21
Prednisone	Prednisone	81	60
Jardiance	Empagliflozin	80	32
Eliquis	Apixaban	79	30
Pravastatin Sodium	Pravastatin Sodium	79	25
Citalopram Hbr	Citalopram Hydrobromide	75	26
Allopurinol	Allopurinol	74	30
Ozempic	Semaglutide	68	15
Clonazepam	Clonazepam	66	11
Metformin Hcl Er	Metformin Hcl	65	21
Doxycycline Hyclate	Doxycycline Hyclate	64	56
Pregabalin	Pregabalin	62	18
Clopidogrel	Clopidogrel Bisulfate	58	20
Buspirone Hcl	Buspirone Hcl	56	19
Cephalexin	Cephalexin	52	48
Glipizide Er	Glipizide	51	15
Ropinirole Hcl	Ropinirole Hcl	49	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	14
Tramadol Hcl	Tramadol Hcl	48	13
Duloxetine Hcl	Duloxetine Hcl	47	19
Methocarbamol	Methocarbamol	47	19
Nystatin	Nystatin	46	24
Triamcinolone Acetonide	Triamcinolone Acetonide	46	34
Tizanidine Hcl	Tizanidine Hcl	44	19
Bupropion Xl	Bupropion Hcl	43	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	15
Lorazepam	Lorazepam	42	13
Meclizine Hcl	Meclizine Hcl	42	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	16
Venlafaxine Hcl Er	Venlafaxine Hcl	40	13
Azithromycin	Azithromycin	39	34
Ezetimibe	Ezetimibe	39	15
Mirtazapine	Mirtazapine	38	11
Diclofenac Sodium	Diclofenac Sodium	37	16
Fluoxetine Hcl	Fluoxetine Hcl	36	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	33
Januvia	Sitagliptin Phosphate	35	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	13
Mupirocin	Mupirocin	34	26
Glipizide	Glipizide	33	13
Promethazine Hcl	Promethazine Hcl	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	12
Bumetanide	Bumetanide	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	23
Atenolol	Atenolol	29	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	13
Hydroxyzine Hcl	Hydroxyzine Hcl	29	14
Labetalol Hcl	Labetalol Hcl	29	suppressed
Diazepam	Diazepam	28	suppressed
Spironolactone	Spironolactone	28	11
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Glimepiride	Glimepiride	27	13
Topiramate	Topiramate	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	12
Alendronate Sodium	Alendronate Sodium	24	suppressed
Potassium Chloride	Potassium Chloride	24	13
Klor-Con M20	Potassium Chloride	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Ondansetron Odt	Ondansetron	20	14
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Fluconazole	Fluconazole	19	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Epinephrine	Epinephrine	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	12
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Amoxicillin	Amoxicillin	17	12
Ibuprofen	Ibuprofen	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Colchicine	Colchicine	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Cefdinir	Cefdinir	13	12
Donepezil Hcl	Donepezil Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error